LOGIN
THR: Celecoxib more effective than ibuprofen in prevention of heterotopic bone formation
August 2013
THR: Celecoxib more effective than ibuprofen in prevention of heterotopic bone formation
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: A PROSPECTIVE RANDOMISED TRIAL
J Bone Joint Surg Br. 2007 Feb;89(2):155-9.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
250 patients with severe hip osteoarthritis were randomized to either receive ibuprofen or celecoxib to determine the relative benefits of these drugs in preventing heterotopic ossification following total hip replacement (THR). The results at 3 months post-op indicated that a ten day trial of celecoxib during the post-op period reduced the risk of heterotopic ossification.
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.